Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of ShenGuo LaoNian cold granule for common cold with qi-deficiency syndrome
ChiCTR-IPR-14005662Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of shenguo laonian ganmao granules in nasopharyngitis (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Time to disappearance of common cold symptoms, Time to disappearance of individual common cold symptoms and 3 more. Started Dec 2014; status: recruiting.
02
Drugs
shenguo laonian ganmao granules
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on ChiCTR-IPR-14005662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005662.